Reminders embedded in percutaneous coronary intervention (PCI) reports to optimize discharge diabetes mellitus care (REMIND-DM): Rationale, design, and baseline characteristics
Study context
- Population
- Patients with type 2 diabetes undergoing angiography at PCI sites within the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) quality improvement collaborativeparticipating PCI sites randomized, caring for 7,045 patients over the study period
- Participants
- 23 patients
- Planned comparison
- Quality improvement intervention vs usual care
- Primary endpoint
- new prescription of SGLT2 inhibitor or GLP-1RA among eligible patients at discharge after PCI
- Follow-up
- Discharge after PCI
Methodological detailsdifference-in-difference design
- Difference-in-difference design
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Reminders embedded in PCI reports to optimize discharge diabetes mellitus care (REMIND-DM): Rationale, design, and baseline characteristics. Am Heart J. Published 21 February 2025. doi:10.
Summarised from the published abstract; every number is checked against it